Nursing Process Approach 10th Edition
2025/2026 True Exam Version | 200 Actual Questions | Verified, Correct Answer
Key | A+ Standard
EXAM OVERVIEW
The Test Bank Pharmacology A Patient- Centered Nursing Process Approach 10th
Edition delivers a realistic and fully verified 2025/2026 exam experience designed to
strengthen mastery and test readiness. Featuring 200 carefully structured questions
and professional-level accuracy, this resource enhances critical reasoning and
supports confident performance, ideal for students seeking reliable, high-quality exam
preparation at the University of California, where authenticity, accuracy, and verified
answers are paramount for achieving exceptional results.
EXAM FEATURES
• 200 exam-accurate questions aligned with standards for comprehensive preparation.
• Coverage of 53 domains for complete mastery of the nursing pharmacology process.
• Verified accuracy and high-yield content for efficient and effective studying.
• Realistic exam simulations to build confidence and test-taking skills.
• Detailed explanations and answers to reinforce learning and enhance retention.
CORE TESTING AREAS
→ Acid (2 Questions)
→ Analgesics (4 Questions)
→ Anti (4 Questions)
→ Antiarrhythmics (4 Questions)
→ Antibiotics & Resistance Mechanisms (4 Questions)
→ Anticoagulants (2 Questions)
→ Antiemetics (2 Questions)
→ Antiepileptics (4 Questions)
→ Antihistamines & Leukotriene Modifiers (4 Questions)
→ Antihypertensives (4 Questions)
→ Antiplatelets (2 Questions)
→ Antivirals, Antifungals, Antituberculosis Drugs (4 Questions)
→ Assessment (4 Questions)
→ Autonomic Nervous System Drugs (8 Questions)
Page 1
,→ Bronchodilators (4 Questions)
→ Cardiovascular Pharmacology (8 Questions)
→ Central Nervous System Agents (8 Questions)
→ Complementary & Alternative Therapies (2 Questions)
→ Corticosteroids (4 Questions)
→ Drug Classification & Nomenclature (4 Questions)
→ Endocrine Medications (6 Questions)
→ Error Reporting & Prevention Strategies (4 Questions)
→ Evaluation & Documentation (2 Questions)
→ Foundations Of Pharmacology (8 Questions)
→ Gastrointestinal Medications (2 Questions)
→ Geriatrics (2 Questions)
→ Heart Failure Therapies (4 Questions)
→ Hematologic Agents (2 Questions)
→ Herbal Supplements (2 Questions)
→ High (4 Questions)
→ Hormone Replacement Therapies (4 Questions)
→ Implementation (4 Questions)
→ Insulin & Oral Antidiabetics (4 Questions)
→ Interactions With Traditional Meds (2 Questions)
→ Laxatives & Antidiarrheals (2 Questions)
→ Medication Safety & Error Prevention (4 Questions)
→ Nursing Diagnoses Related To Medication Therapy (4 Questions)
→ Parasympathomimetics & Anticholinergics (4 Questions)
→ Patient (4 Questions)
→ Pediatrics (2 Questions)
→ Pharmacodynamics (4 Questions)
→ Planning & Goal Setting (4 Questions)
→ Pregnancy & Lactation (2 Questions)
→ Principles Of Antimicrobial Stewardship (4 Questions)
→ Renal/hepatic Impairment Dosing Considerations (2 Questions)
→ Respiratory & Allergy Drugs (6 Questions)
→ Rights Of Medication Administration (4 Questions)
→ Routes Of Administration (4 Questions)
→ Sedatives/hypnotics (4 Questions)
→ Special Populations (2 Questions)
→ Sympathomimetics & Blockers (4 Questions)
→ Thrombolytics (2 Questions)
→ Thyroid & Adrenal Medications (6 Questions)
Page 2
,Foundations Of Pharmacology (8 Questions)
Question 1
A 68-year-old male with chronic kidney disease stage 4 is prescribed gentamicin for a
urinary tract infection. The nurse plans to monitor serum drug concentrations to ensure
therapeutic effectiveness while avoiding toxicity. Considering the patient's reduced renal
function, which pharmacokinetic parameter should be primarily evaluated to adjust the
dosing regimen appropriately?
A. Volume of distribution
B. Clearance
C. Bioavailability
D. Half-life
Correct Answer
Clearance
Rationale:
Renal impairment lowers drug clearance, making clearance the key parameter for dose adjustments to
prevent accumulation and toxicity.
Page 3
, Question 2
A 45-year-old woman with moderate persistent asthma is prescribed inhaled albuterol
(salbutamol) via a metered‑dose inhaler (MDI) for acute symptom relief. She reports that
the medication takes several minutes to relieve her wheezing, which is longer than
expected. The nurse reviews the pharmacokinetic properties of albuterol and the
technique for MDI use. Which factor most likely contributes to the delayed onset of action
in this patient?
A. Albuterol undergoes extensive first‑pass hepatic metabolism, reducing its
bioavailability.
B. The patient's inspiratory flow rate during inhalation is insufficient to aerosolize the
medication effectively.
C. Albuterol's low lipid solubility limits its ability to penetrate airway tissues quickly.
D. High protein binding of albuterol decreases the free fraction available to act on
bronchial smooth muscle.
Correct Answer
The patient's inspiratory flow rate during inhalation is insufficient to aerosolize the
medication effectively.
Rationale:
Adequate inspiratory flow is essential for optimal aerosol deposition; insufficient flow delays drug reaching
airway receptors, prolonging onset.
Page 4